[Immunobiological aspects of multiple sclerosis]. 1978

O Abramsky, and R P Lisak

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

O Abramsky, and R P Lisak
September 1988, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
O Abramsky, and R P Lisak
December 2018, Current opinion in neurology,
O Abramsky, and R P Lisak
January 1975, Annals of clinical and laboratory science,
O Abramsky, and R P Lisak
January 1982, Hepatology (Baltimore, Md.),
O Abramsky, and R P Lisak
January 1978, Advances in experimental medicine and biology,
O Abramsky, and R P Lisak
July 2011, The Lancet. Neurology,
O Abramsky, and R P Lisak
August 1963, Deutsche Zeitschrift fur Nervenheilkunde,
O Abramsky, and R P Lisak
June 1992, Seminars in neurology,
O Abramsky, and R P Lisak
August 1992, Versicherungsmedizin,
O Abramsky, and R P Lisak
May 1982, Physiotherapy,
Copied contents to your clipboard!